Trial of intraventricular ribavirin and interferon-α combination therapy for subacute sclerosing panencephalitis (SSPE) in Japan

No To Hattatsu

Volumn 35, Issue 4, 2003, Pages 321-326

  Tomoda, Akemi ^a   Nomura, Keiko ^a   Shiraishi, Seiji ^a   Miike, Teruhisa ^a   Hamada, Akinobu ^a   Hosoya, Mitsuaki ^b  

^a KUMAMOTO UNIV SCHOOL OF MEDICINE   (Japan)

^b FUKUSHIMA MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; MEASLES ANTIBODY; RIBAVIRIN;

ANTIBODY TITER; ARTICLE; CEREBROSPINAL FLUID LEVEL; CLINICAL ARTICLE; CLINICAL FEATURE; CLINICAL TRIAL; DISEASE CLASSIFICATION; DISEASE COURSE; DRUG EFFICACY; DRUG MEGADOSE; DRUG SAFETY; FEMALE; HEADACHE; HUMAN; INFANT; JAPAN; LIP DISEASE; MALE; MONOTHERAPY; ONSET AGE; PRESCHOOL CHILD; SIDE EFFECT; SOMNOLENCE; SUBACUTE SCLEROSING PANENCEPHALITIS; VIRUS LATENCY;

ADOLESCENT; ADULT; ANTIVIRAL AGENTS; CHILD; CHILD, PRESCHOOL; DRUG THERAPY, COMBINATION; HUMANS; INJECTIONS, INTRAVENTRICULAR; INTERFERON-ALPHA; MALE; QUESTIONNAIRES; RIBAVIRIN; SUBACUTE SCLEROSING PANENCEPHALITIS;

EID: 0038267679     PISSN: 00290831     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Swaiman KF, Ashwal S, eds. Pediatric neurology. Principles and practice. Vol. 1. 2nd ed. St Louis · Baltimore · Boston · Chicago · London · Madrid · Philadelphia · Sydney · Toronto: CV Mosby, 1999:671-9.
2. Hummel KB, Vanchiere JA, Bellini WJ. Restriction of fusion protein mRNA as a mechanism of measles virus persistence. Virology 1994;202:665-72.
3. Jabbour JT, Duenas DA, Modlin J. SSPE: clinical staging, course and frequency. Arch Neurol 1975;32:493-4.
4. Tomoda A, Miike T, Miyagawa S, Negi A, Takeshima H. Subacute sclerosing panencephalitis and chorioretinitis. Brain Dev 1997;19:55-7.
5. Jones CE, Dyken PR, Huttenlocher PR, Jabbour JT, Maxwell KW. Inosiplex therapy in subacute sclerosing panencephalitis. A multicentre, non-randomised study in 98 patients. Lancet 1982;1:1034-7.
6. Fukuyama Y, Nihei K, Matsumoto S, et al. Clinical effects of MND-19 (Inosiplex) on subacute sclerosing panencephalitis - a multi-institutional collaborative study - The Inosiplex-SSPE Research Committee. Brain Dev 1987;9:270-82.
7. Dyken PR, Swift A, Durant RH. Long-term follow-up of patients with subacute sclerosing panencephalitis treated with inosiplex. Ann Neurol 1982;11:359-64.
8. Anlar B, Yalaz K, Oktem F, Kose G. Long-term follow up of patients with subacute sclerosing panencephalitis treated with intraventricular α-interferon. Neurology 1997;48:526-8.
9. Gokcil Z, Odabashi Z, Demirkaya S, Eroglu E, Vural O. Alpha-interferon and isoprinosine in adult-onset subacute sclerosing panencephalitis. J Neurol Sci 1999; 162:62-4.
10. Honda Y. Hosoya M, Ishii T, Shigeta S, Suzuki H. Effect of ribavirin on subacute sclerosing panencephalitis virus infections in hamsters. Antimicrob Agents Chemother 1994;38:653-5.
11. Takahashi T, Hosoya M, Kimura K, et al. The cooperative effect of interferon- α and ribavirin on subacute sclerosing panencephalitis (SSPE) virus infections, in vitro and in vivo. Antiviral Res 1998;37:29-35.
12. Tomoda A, Shiraishi S, Hosoya M, Hamada A, Miike T. Combined treatment with interferon-α and ribavirin for subacute sclerosing panencephalitis. Pediatr Neurol 2001;24:54-9.
13. Hosoya M, Shigeta S, Mori S, et al. High dose intravenous ribavirin therapy for subacute sclerosing panencephalitis (SSPE). Antimicrob Agents Chemother 2001;45:943-5.
14. Poynard T, Marcellin P, Lee SS, et al. Randomised trial of interferon α2b plus ribavirin for 48 weeks or for 24 weeks versus interferon α2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus. Lancet 1998;352:1426-32.
15. Ogle JW, Toltzis P, Parker WD, et al. Oral ribavirin therapy for subacute sclerosing panencephalitis. J Infect Dis 1989;159:748-50.
16. Ross LA, Kim KS, Mason WH, Gomperts E. Successful treatment of disseminated measles in a patient with acquired immunodeficiency syndrome: consideration of antiviral and passive immunotherapy. Am J Med 1990; 88:313-4.